S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|Start Premium Trial||Register For Free|
|P||F||Fund Financial Data (13,000+ funds)|
|P||F||Stock Financial Data (7,000+ stocks)|
|P||F||Stock and Fund Screeners (basic)|
|P||F||Investing Articles and Market Commentary|
|P||F||Articles Archive (>30 days)|
|P||F||Discuss (dozens of stock, fund, bond, and general bulletin boards)|
|P||F||Portfolio Manager (basic)|
|P||F||Morningstar Investment Classroom|
|P||F||Access Your Portfolio Anytime, Anywhere via Your Mobile Device|
|P||Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)|
|P||Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)|
|P||Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)|
|P||Portfolio Monitor (monthly and on-demand personalized portfolio statements)|
|P||Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters|
|P||Discounts on Morningstar newsletters, books, seminars, and more|
Join Morningstar today. It's Free.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.
|BioDelivery Sciences Appoints Ernest De Paolantonio as Chief Financial Officer (2013/10/21)|
|Positive FDA Meeting Confirms BDSI Phase 3 Program for Clonidine Topical Gel for Treatment of Painful Diabetic Neuropathy (2013/12/2)|
|BioDelivery Sciences Provides Business Review and Update in Conjunction with Filing of Second Quarter 2013 Financials ()|
|BioDelivery Sciences Announces Hiring of David Acheson as Vice President of Sales and Managed Markets (2013/12/3)|
|BioDelivery Sciences Provides Business Review and Update in Conjunction with Filing of Third Quarter 2013 Financials (2013/11/12)|
|BioDelivery Sciences Announces Submission of NDA for BUNAVAIL ()|
|BioDelivery Sciences to Present at the Stifel Nicolaus 2013 Healthcare Conference (2013/9/6)|
|BioDelivery Sciences to Present at the 25th Annual Piper Jaffray Healthcare Conference (2013/11/25)|
|BioDelivery Sciences Announces FDA Acceptance of BUNAVAIL NDA for Filing (2013/10/9)|
|Endo and BioDelivery Sciences Provide Update on BEMA Buprenorphine Phase III Development Program (2013/9/4)|
Click above to view more mutual fund data and stats for bdsi - BioDelivery Sciences International, Inc..